Companies›Healthcare›Healthcare›Healthcare Services

SHARMA EAST INDIA HOSPITALS &

Healthcare › Healthcare Services
₹82.00
at close · 27 Oct 2026
▲ 1.95 (+2.44%)

Latest filings

  1. Routine RTA compliance certificate for share dematerialization · Compliance
  2. AGM voting results: all 3 resolutions passed unanimously · Board & Shareholder Meetings
  3. 37th AGM held on Sep 30, 2026 - proceedings summary · Board & Shareholder Meetings
All filings ↓
Ask Nexa about SHARMA EAST INDIA HOSPITALS &

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates a single hospital in Jaipur (marketed as 'Jaipur Hospital') providing inpatient care, surgeries and related medical services under the registered name Sharma East India Hospitals & Medical Research Ltd. For FY26, total operating income stood at ₹3,608.91 lakhs, up roughly 19.6% from ₹3,018.53 lakhs in FY25, with the H1 FY26 filing attributing the rise to an uptick in patient admissions and surgery volumes. Net profit after tax, however, was broadly flat at ₹124.27 lakhs in FY26, and the FY26 EBITDA margin was around 10.56%. The cost structure is led by other operating expenses (36.0% of revenue), followed by materials (15.0% — medical consumables and pharmacy) and employee costs (13.9% — doctors, nurses and support staff), with depreciation at 4.8% and capex at 2.2% of revenue. The H1 FY26 results flagged a swing in operating cash flow to ₹(250.65) lakhs on higher receivables and inventory build-up, and short-term borrowings rose to ₹427.31 lakhs. The business runs from one site in Jaipur under Managing Director Dr. Shailendra Kumar Sharma, and is a small-cap healthcare services provider listed on BSE.

Operating scale
FY26 total operating income
₹3,608.91 lakhsFY26
FY26 net profit after tax
₹124.27 lakhsFY26
FY26 EBITDA margin
10.56%FY26
Q2 FY26 revenue from operations
₹938.45 lakhsQ2 FY26
Short-term borrowings
₹427.31 lakhsH1 FY26
Sites
Single hospital in Jaipur (Jaipur Hospital)FY26
Who pays it
Patients seeking inpatient and surgical care, primarily in and around Jaipur, Rajasthan.
Biggest cost
Other operating expenses at 36.0% of revenue, with materials (medical consumables, pharmacy) at 15.0% the largest direct input.
Kind of business
Small-cap, single-site hospital operator with asset-heavy infrastructure and a service-led revenue model.
Where it sits
BSE-listed hospital company operating from Jaipur in the small-cap healthcare services segment, with FY26 total operating income of ₹3,608.91 lakhs and total assets of ₹3,292 lakh.
Market Cap
₹27 Cr
P / E (TTM)
22.7×
EV / EBITDA
9.1×
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
15.4%▲
ROCE (5y median)
ROE 9.1% (5y median) · margin 10.6%
Leverage
0.53·
Debt / Equity · moderate
Net debt ₹6.83 Cr
Revenue FY20→FY26
2.2×▲
Margin +1.6 pts
₹16 Cr → ₹36 Cr
Cash conversion
1.04×▲
Operating cash ÷ profit · 5 yrs
₹5 Cr on ₹5 Cr
Moves on a normal day
2.46%·
Median daily move
Last 265 sessions · the yardstick for filing-day moves
Where it sits among 29 Healthcare Service Provider peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#12/25
P/B#12/24
ROCE#10/29
ROE#10/24
Debt / Equity#18/23
EBITDA margin#17/24
Revenue growth#17/25
Profit growth#18/25

Scorecard

Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice

Strengths
Returns on capital 15.4% (5-year median)
#10 of 29 in Healthcare Service Provider on the latest reported figures
Over 5 years it reported ₹4.80 Cr of profit and ₹5.00 Cr of operating cash — 1.04×
Profit is converting into cash
Concerns
Carries more debt than its peers — 0.53× equity
higher than 77% of its 23 Healthcare Service Provider peers

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from SHARMA EAST INDIA HOSPITALS &'s filed financials and exchange disclosures

What does SHARMA EAST INDIA HOSPITALS & do?

SHARMA EAST INDIA HOSPITALS & is a Healthcare Services company listed on BSE.

Is SHARMA EAST INDIA HOSPITALS & profitable?

Yes. Over the trailing twelve months SHARMA EAST INDIA HOSPITALS & reported a net profit of ₹1.18 Cr on revenue of ₹37 Cr.

Does SHARMA EAST INDIA HOSPITALS & pay a dividend?

Not in the latest reported year — SHARMA EAST INDIA HOSPITALS &'s dividend payout for FY26 was nil.

Is SHARMA EAST INDIA HOSPITALS & debt-free?

No. It reported borrowings of ₹7.29 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹6.83 Cr after cash. Debt stands at 0.53× equity. That is higher than 77% of its 23 Healthcare Service Provider peers.

Is SHARMA EAST INDIA HOSPITALS & expensive compared with its peers?

On trailing P/E, SHARMA EAST INDIA HOSPITALS & ranks 12 of 25 in Healthcare Service Provider — cheaper than 54% of them, against an industry median of 23.4×. This is a position, not a valuation judgement.

How much does the SHARMA EAST INDIA HOSPITALS & share price move in a day?

On a typical session SHARMA EAST INDIA HOSPITALS & moves 2.46% — that is the median absolute close-to-close move across its last 265 trading days. MarketPing measures each filing's price reaction against it.

Where can I track SHARMA EAST INDIA HOSPITALS &'s announcements?

Every NSE and BSE filing by SHARMA EAST INDIA HOSPITALS & appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.